Obesity and Dyslipidemia

被引:162
|
作者
Franssen, Remco [1 ]
Monajemi, Houshang [1 ]
Stroes, Erik S. G. [1 ]
Kastelein, John J. P. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Obesity; Adipocyte dysfunction; Dyslipidemia; Hyperlipidemia; Lipid metabolism; NONALCOHOLIC FATTY LIVER; ESTER TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIPOPROTEIN-LIPASE; INCREASED PLASMA; GLUCOSE; CHOLESTEROL;
D O I
10.1016/j.mcna.2011.06.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The alarming and still increasing prevalence of obesity and associated cardiovascular risk raises much concern. The increase in cardiovascular risk depends to a significant extent on the changes in lipid profiles as observed in obesity. These changes are decreased high-density lipoprotein cholesterol and increased triglyceride levels. Much effort has already been expended into the elucidation of the mechanisms behind these obesity-associated lipid changes. Insulin resistance certainly plays a central role and, in addition, both hormonal and neurologic pathways have recently been found to play an important role. This article focuses on the mechanisms involved in the development of the proatherogenic lipid changes associated with obesity.
引用
收藏
页码:893 / +
页数:11
相关论文
共 50 条
  • [21] Obesity and Abdominal Adiposity in Diabetic Dyslipidemia
    Sankhla, Manisha
    Mathur, Keerti
    Rathor, Jai Singh
    Gahlot, Sushila
    Agrawal, R. P.
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2011, 26 (04) : 426 - 427
  • [22] Obesity and Abdominal Adiposity in Diabetic Dyslipidemia
    Manisha Sankhla
    Keerti Mathur
    Jai Singh Rathor
    Sushila Gahlot
    R. P. Agrawal
    Indian Journal of Clinical Biochemistry, 2011, 26 (4) : 426 - 427
  • [23] Abdominal Obesity, Dyslipidemia and Blood Pressure
    Miguel Soca, Pedro Enrique
    FINLAY, 2015, 5 (04): : 218 - 219
  • [24] Dyslipidemia in Obesity: Mechanisms and Potential Targets
    Klop, Boudewijn
    Elte, Jan Willem F.
    Cabezas, Manuel Castro
    NUTRIENTS, 2013, 5 (04): : 1218 - 1240
  • [25] Pharmacogenomics analysis of dyslipidemia and obesity model in zebrafish
    Oka, Takehiko
    Shimada, Yasuhito
    Zang, Liqing
    Tanaka, Toshio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 108P - 108P
  • [26] Dyslipidemia of insulin resistance and obesity: Gender differences
    Aikawa, K
    Retzlaff, B
    Fish, B
    Walden, C
    Kahn, S
    Knopp, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 260 - 260
  • [27] Insulin resistance and atherogenic dyslipidemia in childhood obesity
    Felszeghy, E
    Fejes, M
    Ilyés, I
    INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 : S148 - S148
  • [28] Treatment of HTA and dyslipidemia according to the severity of the obesity
    Pannier, B
    Fiquet, B
    Verpilleux, MP
    Yau, C
    Francillon, A
    Basdevant, A
    DIABETES & METABOLISM, 2006, 32 : S95 - S95
  • [29] Dyslipidemia of insulin resistance and obesity: Gender differences
    Aikawa, K
    Retzlaff, B
    Fish, B
    Levitz, M
    Walden, C
    Khan, SE
    Knopp, RH
    CIRCULATION, 2002, 106 (19) : 75 - 75
  • [30] COMBINED HYPOLIPEMIC TREATMENT OF OBESITY WITH SEVERE DYSLIPIDEMIA
    TESTA, I
    POLENTA, M
    MONTEBURINI, T
    BONI, M
    DESIO, G
    MAZZANTI, L
    PRESSE MEDICALE, 1995, 24 (01): : 10 - 14